STRYKER CORP Derivative, Net Hedge Ineffectiveness Gain (Loss)
STRYKER CORP (SYK) reported Derivative, Net Hedge Ineffectiveness Gain (Loss) of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeNetHedgeIneffectivenessGainLoss · last filed 2018-10-26
- STRYKER CORP derivative, net hedge ineffectiveness gain (loss) for the quarter ending 2018-09-30 was $0.00.
- STRYKER CORP derivative, net hedge ineffectiveness gain (loss) for the quarter ending 2018-06-30 was $0.00.
- STRYKER CORP derivative, net hedge ineffectiveness gain (loss) for the quarter ending 2018-03-31 was $0.00.
| Period end | Derivative, Net Hedge Ineffectiveness Gain (Loss) 3 month | Derivative, Net Hedge Ineffectiveness Gain (Loss) 6 month | Derivative, Net Hedge Ineffectiveness Gain (Loss) 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $0.00 derived: sum of 2 quarters · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $0.00 10-Q · filed 2018-07-25 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |